Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.

Revenue
+4.29%
EPS
+2.17%
Free cash flow
+27.0%
Total debt
−18.1%

Quarter to September 2026, against a year earlier

150.97 8.46 −5.31%
Market cap
$16.8B
P/E
71.9×
Fwd P/E
66.2×
Dividend yield
0.19%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100

Revvity Inc. (RVTY) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Revvity Inc. (RVTY) trades at a EV/Sales of 6.6×. Over the past ten years it has ranged from 2.6× (February 2016) to 7.8× (August 2022); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 5.2× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 4.8× (16.53%)
FY2024 5.7× (2.52%)
FY2023 5.8× (11.03%)
FY2022 6.6× (9.39%)
FY2021 7.2× 9.70%
FY2020 6.6× 50.65%
FY2019 4.4× 16.97%
FY2018 3.7× (14.75%)
FY2017 4.4× 43.35%
FY2016 3.1× (5.09%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 6.7× 33.40%
Jun 2026 5.0× 19.78%
Mar 2026 4.2× (11.95%)
Dec 2025 4.8× 7.86%
43 more quarters

Against its own ten years

Low 2.6× High 7.8×
Ten-year median 4.6×
Current reading's percentile 90

EV/Sales against peers

Company EV/Sales
ICLR ICON PLC compare 2.4×
LH Labcorp Holdings Inc. compare 2.4×
DGX Quest Diagnostics Incorporated compare 2.8×
CRL Charles River Laboratories International, Inc. compare 4.3×
QGEN QIAGEN N.V. compare 5.4×
MEDP Medpace Holdings, Inc. compare 6.0×
RVTY Revvity Inc. 6.6×
ILMN Illumina, Inc. compare 7.2×
GH Guardant Health, Inc. compare 16.6×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on RVTY